Log In
Print
BCIQ
Print
Print this Print this
 

Ammonul

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionCombination of 10% sodium phenylacetate and 10% sodium benzoate
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationUrea cycle disorder (UCD)
Indication DetailsTreat urea cycle disorder (UCD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today